Skip to main content
Caplight Logo









Wild Bioscience

Wild Bioscience

Private
AbingdonHealthcare & Life Scienceshttps://www.wildbioscience.com/

Last Round

Series A

Jul 31, 2026

Total Funding Raised

$168.32M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Wild Bioscience is an agritech company that develops high-yielding, climate-resilient crop varieties by using machine learning and plant biology to identify beneficial traits in wild plants.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Environmental Monitoring

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Keywords

agricultural biotechnologyagtechprecision breedingcomputational genomicstrait discoverygene editingCRISPRclimate-resilient cropscrop designgenetically optimized seedscarbon sequestrationsynthetic biologyAI-driven biologybiotech R&Dbio-design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wild Bioscience Comparables

Compare Wild Bioscience with similar companies based on industry and business-model similarity.

Wild Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phytoform Labs
84%
The Traits Company
84%
Rainbow Crops
83%

Wild Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 31, 2026
Series AOct 16, 2025
GrantJul 1, 2022

Key People

Founding team and executive leadership

Ross Hendron

CEO & Co-Founder

Founding Team

Samuel Gattis

Chief Technology Officer

Executive Team

Wild Bioscience Investors

Notable investors and investment history

Wild Bioscience investors
InvestorRounds
Innovate UKGrant
Braavos Investment AdvisersSeed, Series A
Oxford Science EnterprisesSeries A, Seed
University of OxfordSeries A
Innovate UKSeed
Oxford Science EnterprisesSeries A
Braavos CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 31, 2026

    $75M round led by Ellison Institute of Technology.

  • Jan 1, 2026

    Company is a spin-out from Oxford University.

Wild Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wild Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wild Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersAbingdon
Employee Range40
Year Founded2021
Last FundingJul 31, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?